Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Joseph Thome's Stock Ratings
TD Cowen Analyst
Joseph Thome is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-6.10%
Smart Score
Overall Average Return Percentile
23rd
Number of Ratings
32
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/05/2025 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -17.81% | $50 → $63 | Maintains | Hold | Get Alert | |
| 10/31/2025 | ARDX | Buy Now | Ardelyx | $6.12 | 63.4% | $9 → $10 | Maintains | Buy | Get Alert | |
| 09/24/2025 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | 48.21% | → $95 | Initiates | → Buy | Get Alert | |
| 05/13/2025 | DRUG | Buy Now | Bright Minds Biosciences | $85.67 | — | — | Initiates | → Buy | Get Alert | |
| 11/25/2024 | VRDN | Buy Now | Viridian Therapeutics | $33.03 | — | — | Initiates | → Buy | Get Alert | |
| 10/25/2024 | MRNS | Buy Now | Marinus Pharma | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/21/2024 | UTHR | Buy Now | United Therapeutics | $500.30 | -20.05% | $350 → $400 | Maintains | Buy | Get Alert | |
| 07/11/2024 | UTHR | Buy Now | United Therapeutics | $500.30 | -30.04% | $270 → $350 | Maintains | Buy | Get Alert | |
| 07/02/2024 | RAPP | Buy Now | Rapport Therapeutics | $29.60 | — | — | Initiates | → Buy | Get Alert | |
| 06/18/2024 | AVTE | Buy Now | Aerovate Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 06/17/2024 | ALKS | Buy Now | Alkermes | $28.23 | 20.44% | → $34 | Initiates | → Buy | Get Alert | |
| 04/17/2024 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | $80 → $90 | Maintains | Buy | Get Alert | |
| 04/08/2024 | PRME | Buy Now | Prime Medicine | $4.01 | — | — | Initiates | → Buy | Get Alert | |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $1.82 | — | — | Initiates | → Outperform | Get Alert | |
| 03/01/2024 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -60.86% | $32 → $30 | Maintains | Market Perform | Get Alert | |
| 12/11/2023 | ITCI | Buy Now | Intra-Cellular Therapies | — | — | → $75 | Initiates | → Outperform | Get Alert | |
| 12/08/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | → $45 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/18/2023 | EVLO | Buy Now | Evelo Biosciences | $0.00 | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -47.81% | $47 → $40 | Maintains | Market Perform | Get Alert | |
| 04/10/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | — | — | — | Initiates | → Outperform | Get Alert | |
| 01/05/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert | |
| 12/12/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $43.60 | — | — | Initiates | → Outperform | Get Alert | |
| 12/12/2022 | ACRV | Buy Now | Acrivon Therapeutics | $2.57 | — | — | Initiates | → Outperform | Get Alert | |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | — | — | — | Initiates | → Outperform | Get Alert | |
| 06/29/2022 | AXSM | Buy Now | Axsome Therapeutics | $146.24 | -11.11% | $120 → $130 | Maintains | Outperform | Get Alert | |
| 06/28/2022 | EPZM | Buy Now | Epizyme | — | — | → $1.5 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/31/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | — | — | Initiates | → Outperform | Get Alert | |
| 11/23/2021 | TRDA | Buy Now | Entrada Therapeutics | $11.03 | — | — | Initiates | → Outperform | Get Alert | |
| 07/26/2021 | AVTE | Buy Now | Aerovate Therapeutics | — | — | — | Initiates | → Outperform | Get Alert | |
| 07/15/2021 | ALLK | Buy Now | Allakos | — | — | — | Initiates | → Outperform | Get Alert | |
| 07/01/2020 | MRNS | Buy Now | Marinus Pharma | — | — | — | Initiates | → Outperform | Get Alert | |
| 04/14/2020 | AXSM | Buy Now | Axsome Therapeutics | $146.24 | -35.04% | → $95 | Initiates | → Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved